Etesian Wealth Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$807K Sell
3,399
-85
-2% -$17.7K 0.24% 77
2026
Q1
$736K Sell
3,484
-1,145
-25% -$247K 0.23% 80
2025
Q4
$951K Sell
4,629
-975
-17% -$183K 0.3% 76
2025
Q3
$880K Sell
5,604
-3
-0.1% -$463 0.29% 77
2025
Q2
$942K Sell
5,607
-50
-0.9% -$7.42K 0.35% 69
2025
Q1
$779K Hold
5,657
0.34% 74
2024
Q4
$669K Sell
5,657
-136
-2% -$15.9K 0.3% 79
2024
Q3
$640K Sell
5,793
-52
-0.9% -$5.44K 0.29% 91
2024
Q2
$575K Buy
5,845
+57
+1% +$5.81K 0.32% 87
2024
Q1
$648K Sell
5,788
-870
-13% -$93.9K 0.37% 80
2023
Q4
$668K Sell
6,658
-397
-6% -$39.4K 0.4% 72
2023
Q3
$613K Sell
7,055
-372
-5% -$33.6K 0.41% 74
2023
Q2
$702K Sell
7,427
-706
-9% -$59.6K 0.46% 71
2023
Q1
$614K Sell
8,133
-111
-1% -$8.37K 0.41% 74
2022
Q4
$634K Buy
+8,244
New +$626K 0.46% 74

Other funds holding CAH

Etesian Wealth Advisors's CAH Position: Q2 2026 in Review

Etesian Wealth Advisors reduced its Cardinal Health (CAH) stake by 2.4% in Q2 2026, selling an estimated $17.7K and leaving 3,399 shares worth $807K. The position accounts for 0.24% of the portfolio, ranked #77.

Etesian Wealth Advisors first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. The position peaked at $951K in Q4 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Etesian Wealth Advisors held 3,399 shares of Cardinal Health worth $807K as of Q2 2026.
  • Etesian Wealth Advisors sold 85 Cardinal Health shares in Q2 2026, an estimated $17.7K.
  • Cardinal Health made up 0.24% of Etesian Wealth Advisors's portfolio in Q2 2026, its #77 holding.
  • Etesian Wealth Advisors first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • Etesian Wealth Advisors's Cardinal Health position peaked at $951K in Q4 2025.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Etesian Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.